Acumen Pharmaceuticals, Inc. (ABOS)
2.195
+0.02
(+1.15%)
USD |
NASDAQ |
Jun 09, 16:00
2.195
0.00 (0.00%)
After-Hours: 17:30
Acumen Pharmaceuticals Shareholders Equity (Quarterly) : 87.48M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Savara, Inc. | 176.04M |
| Vericel Corp. | 356.23M |
| Biogen, Inc. | 18.65B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 133.63M |
| Total Liabilities (Quarterly) | 46.15M |
| Debt to Equity Ratio | 0.3562 |
| Current Ratio | 4.554 |
| Net Debt Paydown Yield | -0.17% |